News

Patient organizations should focus on how they can be the most effective by leveraging their strengths to uncover new research opportunities.

The FDA has approved several new therapies this week, including a new two-component Pompe therapy, an extended-release drug for major depression without sexual side effects, and an eye drop for drug-induced dilation. Additionally, the agency has set review dates for several products, including odronextamab for blood cancers, sotatercept for pulmonary arterial hypertension, and Dupixent in young children with eosinophilic esophagitis.

Jeremy Berk, senior vice president of Risk Adjustment Solutions for PopHealthCare and Emcara Health, shares how plans must conduct a detailed analysis of how changes to risk adjustment models impact your plan in order to set an effective go-forward strategy.

Study links inflammatory bowel disease diagnosis to increased gout risk, with Crohns disease and ulcerative colitis linked to 68% and 38% increases in likelihood of developing gout, respectively, relative to counterparts without IBD.

Two posters presented at the European Respiratory Society International Congress found use of Dupixent improved lung function by 12 weeks with sustained responses.

Svetlana Mojsov, Ph.D., was a key part of the team that discovered the function of the hormone glucagon-like peptide 1 (GLP-1) and its role in diabetes and weight loss.

Goldsack discussed applying AI and full-stack virtual care-first solutions in oncology and the Digital Medicine Society’s role in CancerX, one of the Biden administration’s Cancer Moonshot initiatives in a recent interview with Managed Healthcare Executive.

Goldsack also pointed to Podimetrics and its SmartMat product, which detects the warning signs of diabetic foot ulcers, as a digital health success story: “That is the sort of thing we want to see.”

Goldsack also explained the Digital Medicine Society’s role as a convener and developer of evidentiary frameworks in a recent interview with Managed Healthcare Executive.

Two possibly curative gene therapies for the disease, which disproportionately affects Black people, are under consideration by the FDA.

The FDA has approved GSK’s myelofibrosis drug, as well as a new indication for Jardiance and a new dosing regimen for Talicia. The agency has also issued a complete response letter for epinephrine nasal spray and assigned a review date for the gene therapy atidarsagene autotemcel.

Aside from leading Upfront Healthcare’s Bartosch Patient Activation Institute, Lindsay Zimmerman, Ph.D., M.P.H., vice president of the organization, said treating herself to a snack like popcorn dressed in parmesan cheese while in bed is a guilty pleasure for her.

Swoop, a New York-based company, has launched an algorithm that may help people with multiple sclerosis take medications as prescribed.

Lindsay Zimmerman, Ph.D., M.P.H., vice president of Bartosch Patient Activation Institute at Upfront Healthcare, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.

An analysis by 3 Axis Advisors has found that there is a large variability in pharmacy reimbursement of prescription drugs depending on PBM contracts with insurers. This creates a system with huge inconsistences on the prices of both generics and branded products.

Boston Medical Center was named the most racially inclusive hospital by the Lown Institute. A leader of the hospital’s equity efforts touts the value of virtual care.

Findings presented at the European Respiratory Society found that using Dupixent to treat acute exacerbations of chronic obstructive pulmonary disease (COPD) reduced duration of systemic corticosteroid days.

Melissa A. Soliz, J.D., of Coppersmith Brockelman PLC is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Soliz recommends the book, “The Immortal Life of Henrietta Lacks” by Rebecca Skloot to those in healthcare because "it is a compelling portrayal of how the law, ethics, ownership and business interests, and health inequities impact patient care and the advancement of that care from a generational perspective."

Melissa A. Soliz, J.D., a regulatory health care partner of Coppersmith Brockelman PLC, a Phoenix-based law firm with a nationally recognized health care practice, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.

Hannah Ratcliffe, M.Sc., of Waymark, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, she shared one of the best pieces of professional advice she had ever received, which is understanding that every context and situation in healthcare is different from the next.

Sherry Rais, M.Sc., CEO and co-founder, Enthea, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, she recommends "Nickel and Dimed: On (Not) Getting By in America" by Barbara Ehrenreich to not only those in healthcare, but all readers as the book illustrates the ways in which inequality affects people’s access to healthcare.

Hannah Ratcliffe, M.Sc., care model and quality lead at Waymark, a public benefit company using technology-enabled, community-based care to improve access and quality of care for people receiving Medicaid, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.

Jason Prestinario of Particle Health is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Prestinario said sports betting is an interest of his as much of it is built from his background of high school and club college sports, being a fan of competition and even pursuing his career as a data scientist.

Those with certain comorbidities, including peptic ulcer disease and renal failure, were at additional risk of developing C diff infection.

Researchers investigated methods for measuring prior exposure in patients with suspected, undocumented COVID-19 infection to give better access to care and counsel.

Sherry Rais, M.Sc., CEO and co-founder of Enthea, a licensed, third-party administrator of health insurance benefits with a mission to provide safe and affordable access to psychedelic-assisted psychotherapies, starting with ketamine therapy, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.

Researchers of a study investigated the association between health-related physical fitness and liver function indicators in hopes of finding potential preventative measures and personalized exercise prescriptions for those living with liver complications.

The week, the FDA approved Aphexda for use in stem cell mobilization. The agency also assigned action dates for resmetirom to treat patients with NASH and Libervant Film for young children and extended the review for lifileucel to treat melanoma. Additionally, an FDA advisory committee backed the use of Onpattro in cardiomyopathy of ATTR amyloidosis.

The authors found shifting patterns in the effects of obesity, alcohol, and smoking on atrial fibrillation.